EPISODE · Sep 8, 2025 · 24 MIN
Larry Tiffany | CEO, GenrAb – Developing Fully Human Neuroprotective Antibodies for Neurodegenerative Diseases
from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Larry Tiffany, CEO of GenrAb, to explore how the company is developing fully human neuroprotective antibodies to address neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s. Larry discusses GenrAb’s scientific approach, the promise of neuroprotection in slowing disease progression, and the challenges of advancing novel biologics in today’s biotech landscape.Learn more at genecoda.com.Originally recorded and streamed on YouTube Live on June 20, 2025.
What this episode covers
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Larry Tiffany, CEO of GenrAb, to explore how the company is developing fully human neuroprotective antibodies to address neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s. Larry discusses GenrAb’s scientific approach, the promise of neuroprotection in slowing disease progression, and the challenges of advancing novel biologics in today’s biotech landscape.Learn more at genecoda.com.Originally recorded and streamed on YouTube Live on June 20, 2025.
NOW PLAYING
Larry Tiffany | CEO, GenrAb – Developing Fully Human Neuroprotective Antibodies for Neurodegenerative Diseases
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m